Department of Epidemiology St. Luke’s International University Graduate School of Public Health, Tokyo, Japan
Fujita Health University Toyoake, Japan
Search for other papers by Daiki Kobayashi in
Google Scholar
PubMed
Search for other papers by Nagato Kuriyama in
Google Scholar
PubMed
Search for other papers by Keita Hirano in
Google Scholar
PubMed
Department of Epidemiology St. Luke’s International University Graduate School of Public Health, Tokyo, Japan
Search for other papers by Osamu Takahashi in
Google Scholar
PubMed
Search for other papers by Hiroshi Noto in
Google Scholar
PubMed
. Although the association of diabetes with malignancies among diabetic patients compared to nondiabetic patients has been well evaluated, the differences in the incidence of malignancies among diabetic patients in terms of the level of glycemic control are
Search for other papers by Zhou-Qing Kang in
Google Scholar
PubMed
Search for other papers by Jia-Ling Huo in
Google Scholar
PubMed
Search for other papers by Xiao-Jie Zhai in
Google Scholar
PubMed
was the first use of glucose range 80–110 mg/dL to define tight glycemic control (TGC), and then tight control of glycemic target became popular. Many researchers have made attempt to practice perioperative TGC with different upper level of glucose
Search for other papers by Louise Færch in
Google Scholar
PubMed
Department of Cardiology, Department of Growth and Reproduction, Faculty of Health Sciences, Nephrology and Endocrinology H, Hillerød University Hospital, Dyrehavevej 29, DK-3400 Hillerød, Denmark
Search for other papers by Anders Juul in
Google Scholar
PubMed
Search for other papers by Ulrik Pedersen-Bjergaard in
Google Scholar
PubMed
Department of Cardiology, Department of Growth and Reproduction, Faculty of Health Sciences, Nephrology and Endocrinology H, Hillerød University Hospital, Dyrehavevej 29, DK-3400 Hillerød, Denmark
Search for other papers by Birger Thorsteinsson in
Google Scholar
PubMed
cohort of nonpregnant adult patients with type 1 diabetes and to explore whether a similar association exists with mild and biochemical hypoglycemia and with glycemic control as indicated by HbA1c levels. Materials and methods The study is a post hoc
Search for other papers by Aldo Bonaventura in
Google Scholar
PubMed
Department of Internal Medicine, Division of Cardiology, Division of Laboratory Medicine, First Clinic of Internal Medicine, University of Genoa School of Medicine, IRCCS Azienda Ospedaliera Universitaria San Martino – IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Department of Internal Medicine, Division of Cardiology, Division of Laboratory Medicine, First Clinic of Internal Medicine, University of Genoa School of Medicine, IRCCS Azienda Ospedaliera Universitaria San Martino – IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Search for other papers by Fabrizio Montecucco in
Google Scholar
PubMed
Search for other papers by Franco Dallegri in
Google Scholar
PubMed
and compliance with achieving good glycemic control that minimizes the risk of diabetic complications, with a consequent increase in cardiovascular (CV) and neurological morbidities. In this review, based on the material searched for and obtained via
Search for other papers by Michelle J Galvan in
Google Scholar
PubMed
Search for other papers by Michael J Sanchez in
Google Scholar
PubMed
Australian Institute for Musculoskeletal Science (AIMSS), Victoria University, Melbourne, Victoria, Australia
Search for other papers by Andrew J McAinch in
Google Scholar
PubMed
Search for other papers by Jeffrey D Covington in
Google Scholar
PubMed
Search for other papers by Jason B Boyle in
Google Scholar
PubMed
Search for other papers by Sudip Bajpeyi in
Google Scholar
PubMed
lactate accumulation indicating reliance on glucose utilization is similar to previous studies that investigated the effectiveness of NMES on glycemic control ( 19 , 28 , 29 , 44 ). In the present study, lactate AUC was acutely increased in the NMES
Search for other papers by Vânia Benido Silva in
Google Scholar
PubMed
Search for other papers by Liliana Fonseca in
Google Scholar
PubMed
Search for other papers by Maria Teresa Pereira in
Google Scholar
PubMed
Search for other papers by Joana Vilaverde in
Google Scholar
PubMed
Search for other papers by Clara Pinto in
Google Scholar
PubMed
Search for other papers by Fernando Pichel in
Google Scholar
PubMed
Search for other papers by Maria do Céu Almeida in
Google Scholar
PubMed
Search for other papers by Jorge Dores in
Google Scholar
PubMed
, 7 , 8 ). These adverse pregnancy outcomes can be minimized by an optimized glycemic control ( 7 , 8 ). The recommended initial treatment is centered in lifestyle modifications, supported by an individualized medical nutrition therapy and a daily
Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
Search for other papers by Peter Wolf in
Google Scholar
PubMed
Search for other papers by Alexandre Dormoy in
Google Scholar
PubMed
Search for other papers by Luigi Maione in
Google Scholar
PubMed
Search for other papers by Sylvie Salenave in
Google Scholar
PubMed
Search for other papers by Jacques Young in
Google Scholar
PubMed
Search for other papers by Peter Kamenický in
Google Scholar
PubMed
Search for other papers by Philippe Chanson in
Google Scholar
PubMed
( 4 ). Glycemic control is associated with disease activity ( 5 ), but the effects of GH-lowering therapy on glucose metabolism depend on the chosen therapeutic modality. Whereas pituitary surgery and treatment with the GH receptor antagonist
Search for other papers by Hathairat Rueangdetnarong in
Google Scholar
PubMed
Search for other papers by Rattanaporn Sekararithi in
Google Scholar
PubMed
Search for other papers by Thidarat Jaiwongkam in
Google Scholar
PubMed
Search for other papers by Sirinart Kumfu in
Google Scholar
PubMed
Search for other papers by Nipon Chattipakorn in
Google Scholar
PubMed
Search for other papers by Theera Tongsong in
Google Scholar
PubMed
Search for other papers by Phudit Jatavan in
Google Scholar
PubMed
develop overt diabetes mellitus later in life or 20 years later ( 4 ). Therefore, we hypothesize that women with GDM with high oxidative stress markers, even in the case of good glycemic control, may have a higher chance of developing DM type 2 later in
Search for other papers by Jyotsna S Jagai in
Google Scholar
PubMed
U.S. Environmental Protection Agency, Center for Public Health and Environmental Assessment, Research Triangle Park, North Carolina, USA
Search for other papers by Alison K Krajewski in
Google Scholar
PubMed
Search for other papers by Kyla N Price in
Google Scholar
PubMed
Search for other papers by Danelle T Lobdell in
Google Scholar
PubMed
Search for other papers by Robert M Sargis in
Google Scholar
PubMed
improved glycemic control among those with both type 1 and type 2 diabetes improves microvascular outcomes ( 3 , 4 ). Moreover, recent clinical trials employing newer pharmacological approaches show improvements in macrovascular outcomes as well ( 5 , 6
Search for other papers by Jothydev Kesavadev in
Google Scholar
PubMed
Search for other papers by Pradeep Babu Sadasivan Pillai in
Google Scholar
PubMed
Search for other papers by Arun Shankar in
Google Scholar
PubMed
Search for other papers by Gopika Krishnan in
Google Scholar
PubMed
Search for other papers by Sunitha Jothydev in
Google Scholar
PubMed
require insulin therapy due to inadequate glycemic control with oral agents ( 1 ). Metformin and sulfonylureas (SU) are the most commonly used oral antidiabetic agents. However, SU have a greater tendency to cause hypoglycemia and weight gain and hence